Second, although we had studied the potential value of this classification in distinguishing immunotherapeutic responsiveness in four aspects: tumor immunity infiltration, proportion of specific TILs, HLA expression, and PD-L1 expression, real-world data on immunotherapy of the discovery cohort was still missing. Here, CD274 is linked to neoplasm.